Bio Medica Laboratories IPO Day 1 Subscription Status: Issue Subscribed 0.14 Times
By HDFC SKY | Published at: May 21, 2026 01:11 PM IST
Bio Medica Laboratories IPO saw 0.14 times subscription on Day 1 as of May 21, led by the retail category at 0.27 times.
Mumbai, May 21: Bio Medica Laboratories IPO opened for subscription on May 21, 2026, and will remain open until May 25, 2026. The SME issue is a bookbuilt offer of ₹52.43 crore, comprising a fresh issue worth ₹47.19 crore and an offer for sale of ₹5.24 crore.
The company has fixed the price band at ₹132 to ₹139 per share. Investors can bid in lots of 1,000 shares. The IPO is proposed to list on NSE SME, with the tentative listing date set for May 29, 2026.
Bio Medica Laboratories IPO Day 1 Subscription Status
Bio Medica Laboratories IPO was subscribed 0.14 times as of May 21, 2026, 11:33 AM on Day 1.
Retail investors accounted for the highest response among the disclosed categories, with the retail portion subscribed 0.27 times. The NII/HNI category was subscribed 0.01 times, while the QIB portion recorded 0.00 times subscription.
Category-wise Bio Medica Laboratories IPO Subscription Status
| Category | Subscription (x) | Shares Offered | Shares Bid For | Amount (₹ Cr.) |
| QIB (Ex Anchor) | 0.00 | 36,000 | 0 | 0.000 |
| NII/HNI | 0.01 | 17,55,000 | 16,000 | 0.222 |
| Retail | 0.27 | 17,92,000 | 4,78,000 | 6.644 |
| Total | 0.14 | 35,83,000 | 4,94,000 | 6.867 |
Bio Medica Laboratories Day’s Wise Subscription Summary
| Date | QIB | NII/HNI | Retail | Total |
| May 21 2026, Day 1 | 0.00 | 0.01 | 0.27 | 0.14 |
Bio Medica Laboratories IPO Timeline
| Event | Date |
| Issue Open Date | May 21 2026 |
| Issue Close Date | May 25 2026 |
| Basis of Allotment Date | May 26 2026 |
| Initiation of Refunds | May 27 2026 |
| Credit of Shares | May 27 2026 |
| Listing Date | May 29 2026 |
Brief Overview Of The IPO
Bio Medica Laboratories IPO is a ₹52.43 crore book built issue. It consists of a fresh issue of 32,06,000 shares aggregating to ₹47.19 crore and an offer for sale of 3,77,000 shares aggregating to ₹5.24 crore.
The IPO price band is ₹132 to ₹139 per share. The minimum lot size is 1,000 shares. Skyline Financial Services Pvt. Ltd. is the registrar to the issue, while Narnolia Financial Services Ltd. is the book running lead manager. Prabhat Financial Services Ltd. is the market maker.
Bio Medica Laboratories manufactures pharmaceutical parenteral formulations. Its portfolio includes liquid injectables and dry powder injectables, serving human and veterinary healthcare requirements.
Source:
- https://www.nseindia.com/market-data/issue-information?symbol=BMLL&series=SME&type=Active
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Join Us
Add as preferred source on Google
